Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,664.80
(
-0.55%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
109.68
(
2.90%
)
Bitcoin
69,890.92
(
-1.89%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: microcapfun post# 50881

Friday, 08/10/2007 3:03:57 PM

Friday, August 10, 2007 3:03:57 PM

Post# of 257257
Re: HCV arena

#msg-13214528 presents a somewhat outdated overview of the HCV arena from nature.com. Since this article was written, the two main non-interferon immunomodulators (from COLY and ANDS) have been dropped, and the three main polymerase inhibitors (NM283 from NVS/IDIX, R1626 from Roche, and HCV-796 from WYE/VPHM) have run into trouble.

I guess it’s fair to say that HCV is a challenging indication for new molecular entities. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now